136 related articles for article (PubMed ID: 12955748)
1. Toxicokinetic assessment of methylphenidate (Ritalin(R)) in a 13-week oral (gavage) toxicity study in rats using an enantiomeric liquid chromatography/tandem mass spectrometry assay.
Bakhtiar R; Tse FL
Rapid Commun Mass Spectrom; 2003; 17(18):2160-2. PubMed ID: 12955748
[No Abstract] [Full Text] [Related]
2. Toxicokinetic assessment of methylphenidate (Ritalin) enantiomers in pregnant rats and rabbits.
Bakhtiar R; Tse FL
Biomed Chromatogr; 2004 Jun; 18(5):275-81. PubMed ID: 15236434
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetic assessment of methylphenidate (Ritalin) in a 13-week oral toxicity study in dogs.
Bakhtiar R; Ramos L; Tse FL
Biomed Chromatogr; 2004 Jan; 18(1):45-50. PubMed ID: 14872548
[TBL] [Abstract][Full Text] [Related]
4. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
5. Dose-related immunohistochemical and ultrastructural changes after oral methylphenidate administration in cerebrum and cerebellum of the rat.
Bahcelioglu M; Gozil R; Take G; Elmas C; Oktem H; Kadioglu D; Calguner E; Erdogan D; Sargon MF; Yazici AC; Tas M; Bardakci Y; Senol S
World J Biol Psychiatry; 2009; 10(4 Pt 2):531-43. PubMed ID: 19707959
[TBL] [Abstract][Full Text] [Related]
6. Comparative bioavailability of single-dose methylphenidate from a multilayer-release bead formulation and an osmotic system: a two-way crossover study in healthy young adults.
Reiz JL; Donnelly GA; Michalko K
Clin Ther; 2008 Jan; 30(1):59-69. PubMed ID: 18343243
[TBL] [Abstract][Full Text] [Related]
7. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
[TBL] [Abstract][Full Text] [Related]
8. Juvenile toxicity assessment of d,l-methylphenidate in rats.
Beckman DA; Schneider M; Youreneff M; Tse FL
Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):48-67. PubMed ID: 18189274
[TBL] [Abstract][Full Text] [Related]
9. A 90-day oral gavage toxicity study of d-methylphenidate and d,l-methylphenidate in beagle dogs.
Teo SK; Stirling DI; Thomas SD; Evans MG; Khetani VD
Int J Toxicol; 2003; 22(3):215-26. PubMed ID: 12851154
[TBL] [Abstract][Full Text] [Related]
10. Ethylphenidate formation in human subjects after the administration of a single dose of methylphenidate and ethanol.
Markowitz JS; DeVane CL; Boulton DW; Nahas Z; Risch SC; Diamond F; Patrick KS
Drug Metab Dispos; 2000 Jun; 28(6):620-4. PubMed ID: 10820132
[TBL] [Abstract][Full Text] [Related]
11. Quantification of methylphenidate (Ritalin) in rabbit fetal tissue using a chiral liquid chromatography/tandem mass spectrometry assay.
Bakhtiar R; Ramos L; Tse FL
Rapid Commun Mass Spectrom; 2002; 16(1):81-3. PubMed ID: 11754251
[No Abstract] [Full Text] [Related]
12. Developmental toxicity assessment of d,l-methylphenidate and d-methylphenidate in rats and rabbits.
Beckman DA; Schneider M; Youreneff M; Tse FL
Birth Defects Res B Dev Reprod Toxicol; 2008 Oct; 83(5):489-501. PubMed ID: 18924147
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent immunohistochemical changes in rat cornea and retina after oral methylphenidate administration.
Tunc E; Erdogan D; Gozil R; Bahcelioglu M; Calguner E; Take G; Caglar G; Oktem H
Anat Histol Embryol; 2009 Apr; 38(2):128-32. PubMed ID: 19007354
[TBL] [Abstract][Full Text] [Related]
14. Reproductive toxicology. Methylphenidate hydrochloride.
Environ Health Perspect; 1997 Feb; 105 Suppl 1(Suppl 1):319-20. PubMed ID: 9114343
[No Abstract] [Full Text] [Related]
15. Effect of repeated oral therapeutic doses of methylphenidate on food intake and growth rate in rats.
Alam N; Najam R
Pak J Pharm Sci; 2015 Jan; 28(1):9-13. PubMed ID: 25553710
[TBL] [Abstract][Full Text] [Related]
16. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
[TBL] [Abstract][Full Text] [Related]
17. Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form.
Tuerck D; Appel-Dingemanse S; Maboudian M; Pommier F; Wang Y; Sedek G
J Clin Pharmacol; 2007 Jan; 47(1):64-9. PubMed ID: 17192503
[TBL] [Abstract][Full Text] [Related]
18. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of methylphenidate and ritalinic acid in plasma correlations with exhaled breath and oral fluid in healthy volunteers.
Arvidsson M; Dahl ML; Beck O; Ackehed G; Nordin K; Rosenborg S
Eur J Clin Pharmacol; 2020 Feb; 76(2):229-237. PubMed ID: 31786618
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylphenidate (Ritalin) on mammalian myocardial ultrastructure.
Henderson TA; Fischer VW
Am J Cardiovasc Pathol; 1995; 5(1):68-78. PubMed ID: 8838158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
